Introduction

Chapter

Abstract

Metastatic disease is the most lethal aspect of human malignancies, making the understanding and continued research into the process of metastasis a crucial step in treating cancer. The lethality of malignant neoplasms is attributable directly to the development of secondary growths in organs often at a distance from the primary tumor mass. While most primary tumors are treatable and manageable by local resection or irradiation, disseminated cancer cells are often immune to our methods of treatment. Few therapeutic options for patients have demonstrated potential in curing metastatic disease. The molecular mechanisms underlying site-specific metastasis and the factors mediating tumor cell homing remain largely unknown. In this introductory chapter, the metastatic cascade will be reviewed, with emphasis on the individual steps of the metastatic process and the routes of cell dissemination. In addition, the molecular mechanisms driving site-specific metastasis and tumor cell homing to specific sites will be discussed.

Keywords

Migration 

References

  1. Baylin SB, Ohm JE (2006) Epigenetic gene silencing in cancer–a mechanism for early oncogenic pathway addiction? Nat Rev Cancer 6:107–116PubMedCrossRefGoogle Scholar
  2. Bergers G, Benjamin LE (2003) Tumorigenesis and the angiogenic switch. Nat Rev Cancer 3:401–410PubMedCrossRefGoogle Scholar
  3. Cameron MD et al (2000) Temporal progression of metastasis in lung: cell survival, dormancy, and location dependence of metastatic inefficiency. Cancer Res 60:2541–2546PubMedGoogle Scholar
  4. Chambers AF, Groom AC, MacDonald IC (2002) Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2:563–572PubMedCrossRefGoogle Scholar
  5. Christofori G (2003) Changing neighbours, changing behaviour: cell adhesion molecule-mediated signalling during tumour progression. EMBO J 22:2318–2323PubMedCrossRefGoogle Scholar
  6. Cifone MA, Fidler IJ (1981) Increasing metastatic potential is associated with increasing genetic instability of clones isolated from murine neoplasms. Proc Natl Acad Sci U S A 78:6949–6952PubMedCrossRefGoogle Scholar
  7. Eccles SA, Welch DR (2007) Metastasis: recent discoveries and novel treatment strategies. Lancet 369:1742–1757PubMedCrossRefGoogle Scholar
  8. Felding-Habermann B (2003) Integrin adhesion receptors in tumor metastasis. Clin Exp Metastasis 20:203–213PubMedCrossRefGoogle Scholar
  9. Fidler IJ (2003) The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nat Rev Cancer 3:453–458PubMedCrossRefGoogle Scholar
  10. Fidler IJ, Kripke ML (2003) Genomic analysis of primary tumors does not address the prevalence of metastatic cells in the population. Nat Genet 34:23 (author reply 25)PubMedCrossRefGoogle Scholar
  11. Fidler IJ, Gersten DM, Hart IR (1978) The biology of cancer invasion and metastasis. Adv Cancer Res 28:149–250PubMedCrossRefGoogle Scholar
  12. Folkman J (1996) New perspectives in clinical oncology from angiogenesis research. Eur J Cancer 32A:2534–2539PubMedCrossRefGoogle Scholar
  13. Gimbrone MA Jr, Leapman SB, Cotran RS, Folkman J (1972) Tumor dormancy in vivo by prevention of neovascularization. J Exp Med 136:261–276PubMedCrossRefGoogle Scholar
  14. Grossmann J (2002) Molecular mechanisms of “detachment-induced apoptosis–Anoikis”. Apoptosis 7:247–260PubMedCrossRefGoogle Scholar
  15. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57–70PubMedCrossRefGoogle Scholar
  16. Hood JD, Cheresh DA (2002) Role of integrins in cell invasion and migration. Nat Rev Cancer 2:91–100PubMedCrossRefGoogle Scholar
  17. Kaplan RN, Rafii S, Lyden D (2006) Preparing the “soil”: the premetastatic niche. Cancer Res 66:11089–11093PubMedCrossRefGoogle Scholar
  18. Langley RR, Fidler IJ (2007) Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis. Endocr Rev 28:297–321PubMedCrossRefGoogle Scholar
  19. Long L, Nip J, Brodt P (1994) Paracrine growth stimulation by hepatocyte-derived insulin-like growth factor-1: a regulatory mechanism for carcinoma cells metastatic to the liver. Cancer Res 54:3732–3737PubMedGoogle Scholar
  20. Luzzi KJ et al (1998) Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol 153:865–873PubMedCrossRefGoogle Scholar
  21. Minn AJ et al (2005a) Genes that mediate breast cancer metastasis to lung. Nature 436:518–524CrossRefGoogle Scholar
  22. Minn AJ et al (2005b) Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J Clin Invest 115:44–55Google Scholar
  23. Nguyen DX, Massague J (2007) Genetic determinants of cancer metastasis. Nat Rev Genet 8:341–352PubMedCrossRefGoogle Scholar
  24. Nguyen DX, Bos PD, Massague J (2009) Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 9:274–284PubMedCrossRefGoogle Scholar
  25. Paget S (1889) The distribution of secondary growth in cancer of the breast. Lancet 1:3Google Scholar
  26. Palmieri D et al (2006) Brain metastases of breast cancer. Breast Dis 26:139–147PubMedGoogle Scholar
  27. Pozzatti R et al (1986) Primary rat embryo cells transformed by one or two oncogenes show different metastatic potentials. Science 232:223–227PubMedCrossRefGoogle Scholar
  28. Robson EJ, Khaled WT, Abell K, Watson CJ (2006) Epithelial-to-mesenchymal transition confers resistance to apoptosis in three murine mammary epithelial cell lines. Differentiation 74:254–264PubMedCrossRefGoogle Scholar
  29. Saad S, Gottlieb DJ, Bradstock KF, Overall CM, Bendall LJ (2002) Cancer cell-associated fibronectin induces release of matrix metalloproteinase-2 from normal fibroblasts. Cancer Res 62:283–289PubMedGoogle Scholar
  30. Siegel PM, Shu W, Cardiff RD, Muller WJ, Massague J (2003) Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis. Proc Natl Acad Sci U S A 100:8430–8435PubMedCrossRefGoogle Scholar
  31. Sorlie T et al (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 98:10869–10874PubMedCrossRefGoogle Scholar
  32. Steeg PS (2006) Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 12:895–904PubMedCrossRefGoogle Scholar
  33. Thompson EW, Newgreen DF, Tarin D (2005) Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? Cancer Res 65:5991–5995; discussion 5995PubMedCrossRefGoogle Scholar
  34. Trepel M, Arap W, Pasqualini R (2002) In vivo phage display and vascular heterogeneity: implications for targeted medicine. Curr Opin Chem Biol 6:399–404PubMedCrossRefGoogle Scholar
  35. van de Vijver MJ et al (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347:1999–2009PubMedCrossRefGoogle Scholar
  36. Van den Eynden GG et al (2007) Differential expression of hypoxia and (lymph)angiogenesis-related genes at different metastatic sites in breast cancer. Clin Exp Metastasis 24:13–23PubMedCrossRefGoogle Scholar
  37. van ’t Veer LJ et al (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:530–536CrossRefGoogle Scholar
  38. Weiss L (1992) Comments on hematogenous metastatic patterns in humans as revealed by autopsy. Clin Exp Metastasis 10:191–199PubMedCrossRefGoogle Scholar
  39. Weiss L et al (1986) Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies. J Pathol 150:195–203PubMedCrossRefGoogle Scholar
  40. Weiss L et al (1988) Metastatic patterns of renal carcinoma: an analysis of 687 necropsies. J Cancer Res Clin Oncol 114:605–612PubMedCrossRefGoogle Scholar
  41. Welch DR, Goldberg SF (1997) Molecular mechanisms controlling human melanoma progression and metastasis. Pathobiology 65:311–330PubMedCrossRefGoogle Scholar
  42. Wittekind C (2000) Diagnosis and staging of lymph node metastasis. Recent Results Cancer Res 157:20–28PubMedCrossRefGoogle Scholar
  43. Wong SY, Hynes RO (2006) Lymphatic or hematogenous dissemination: how does a metastatic tumor cell decide? Cell Cycle 5:812–817PubMedCrossRefGoogle Scholar
  44. Wyckoff JB, Jones JG, Condeelis JS, Segall JE (2000) A critical step in metastasis: in vivo analysis of intravasation at the primary tumor. Cancer Res 60:2504–2511PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Centre for Genomic RegulationBarcelonaSpain
  2. 2.Clinicial Research & Training, MUHC-RIMcGill UniversityMontrealCanada
  3. 3.Thomas Hecht Family Chair in OphthalmologyMcGill UniversityMontrealCanada
  4. 4.Ophthalmology, Pathology, Oncology, MedicineMcGill UniversityMontrealCanada
  5. 5.Henry C. Witelson Eye Pathology LaboratoryMcGill UniversityMontrealCanada
  6. 6.Melanoma Program, MUHCMcGill UniversityMontrealCanada

Personalised recommendations